HARVARD BIOSCIENCE INC Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Harvard Bioscience Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Harvard Bioscience Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $1.38M, a 36.8% increase year-over-year.
  • Harvard Bioscience Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $5M, a 13.4% increase year-over-year.
  • Harvard Bioscience Inc annual Share-based Payment Arrangement, Expense for 2023 was $5M, a 13.4% increase from 2022.
  • Harvard Bioscience Inc annual Share-based Payment Arrangement, Expense for 2022 was $4.41M, a 5.81% increase from 2021.
  • Harvard Bioscience Inc annual Share-based Payment Arrangement, Expense for 2021 was $4.17M, a 14.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5M +$589K +13.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $4.41M +$242K +5.81% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $4.17M +$522K +14.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $3.65M +$613K +20.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $3.03M -$10K -0.33% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-03-17
2018 $3.04M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.